In this video, Blake Bos outlines three risks to General Motors:
GM rides the highs and lows of the economy. If the European economy falls flat, for example, GM will feel it in its earnings. A substantial unfunded pension liability will eat into earnings for the next few years. Corporate culture has begun to improve, as its high-quality popular new cars bear out. Will the trend continue, or will GM slip back into its past habits of mediocrity?For more details, check out the video.
Worried about GM?
Few companies lead to such strong feelings as General Motors. But ignoring emotions to make good investing decisions is hard. The Fool's premium GM research service�can help, by telling you the truth about GM's growth potential in coming years. (Hint: It's even bigger than you might think. But it's not a sure thing, and we'll help you understand why.) It might help give you the courage to be greedy while others are still fearful, as well as a better understanding of the real risks facing General Motors. Just click here�to get started now.
Top 5 Media Companies To Watch In Right Now: Guided Therapeutics Inc (GTHP)
Guided Therapeutics, Inc., incorporated on October 27, 1992, is a medical technology company focused on developing medical devices. The Company�� primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.
The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions. The product is expected to incorporate a single-use, disposable calibration and alignment component.
The Company competes with Qiagen, MediSpectra, Inc., Merck & Co., Inc., and GlaxoSmithKline PLC.
Advisors' Opinion:- [By CRWE]
Today, GTHP remains (0.00%) +0.000 at $.710 with 44,700 shares in play thus far (ref. google finance Delayed: 11:42AM EDT August 21, 2013).
Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.
Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.
- [By CRWE]
Last Friday, GTHP had shed (-2.16%) down -0.015 at $.679 with 39,538 shares in play at the close (ref. google finance August 23, 2013 ��Close).
Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.
Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.
10 Best Quality Stocks To Invest In Right Now: The Navigators Group Inc.(NAVG)
The Navigators Group, Inc., together with its subsidiaries, engages in underwriting ocean marine, property and casualty, professional liability, and specialty insurance products and services. The company?s marine and inland marine insurance products include marine and energy liability, cargo, craft/fishing vessel, bluewater hull, brownwater hull, protection and indemnity, war, customs bonds, commercial output policy, construction, transportation, specialty, specie, and marine excess-of-loss reinsurance Its property and casualty insurance products comprise general and environmental liability, umbrella and excess, offshore energy, onshore energy, operational engineering, construction, life sciences, exporters package liability, accident and health reinsurance, Latin America property and casualty reinsurance, agriculture reinsurance, professional liability reinsurance, bloodstock, and the U.S. casualty insurance products. The company?s professional liability products inclu de directors and officers, employment practices, fiduciary, crime, accountants professional, lawyers professional, insurance agent errors and omissions, miscellaneous professional, technology and media, design professionals, and real estate agent liability insurance products. The Navigators Group, Inc. distributes its products through global, national, and regional retail and wholesale insurance brokers. The company was founded in 1981 and is based in Rye Brook, New York.
Advisors' Opinion:- [By Ben Levisohn]
Tower Group has dropped 40% to $4.43 today, and some other small insurers are also getting dinged this morning. HCI Group (HCI) has fallen 1.8% to $39.36, Stewart Information Services (STC) has declined 0.7% to $31.36 and the Navigators Group (NAVG) has ticked down 0.4% to $56.10.
- [By CRWE]
The Navigators Group, Inc. (NASDAQ:NAVG) reported that its principal underwriting agency subsidiary, Navigators Management Company, Inc., has expanded Adrien T. Robinson’s responsibilities to include the open-brokerage products of Life Sciences, Global Package, Environmental Casualty, Commercial Auto and Excess Casualty Retail. Mr. Robinson was previously President of the Environmental Casualty division.
- [By Ben Levisohn]
Tower Group has dropped 12% to $3.88 today at 11:39 a.m., while Stewart Information Services (STC) has dipped 0.1% to $31.16, the�Navigators Group�(NAVG) has fallen 1.4% to $54.78 and HCI Group�(HCI) has gained 1% to $38.16.
10 Best Quality Stocks To Invest In Right Now: Anheuser-Busch InBev (BUD)
Anheuser-Busch InBev SA/NV, incorporated on August 2, 1977, is a brewing company. The Company produces, markets, distributes and sells a balanced portfolio of approximately 200 beer brands. These include global flagship brands Budweiser, Stella Artois and Beck��; multi-country brands, such as Leffe and Hoegaarden, and many local champions, such as Bud Light, Skol, Brahma, Quilmes, Michelob, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske and Jupiler. The Company also produces and distributes soft drinks, particularly in Latin America. The Company operates in seven segments: North America, Latin America North, Latin America South, Western Europe, Central & Eastern Europe, Asia Pacific and Global Export & Holding Companies. On October 20, 2010, Companhia de Bebidas das Americas-AmBev (AmBev) and Cerveceria Regional S.A. closed a transaction pursuant, to which they combined their businesses in Venezuela, with Regional owning an 85% interest and AmBev owning the remaining 15% in the new company. On February 28, 2011, the Company closed a transaction with Dalian Daxue Group Co., Ltd and Kirin (China) Investment Co., Ltd to acquire a 100% equity interest in Liaoning Dalian Daxue Brewery Co., Ltd. The Company�� beer portfolio is divided into global, multi-country and local brands. Beer can be differentiated into the categories, such as premium brands; mainstream or core brands, and value, discount or sub-premium brands. The Company also has a presence in the soft drink market in Latin America through its subsidiary AmBev and in the United States through Anheuser-Busch Companies, Inc. (Anheuser-Busch). Soft drinks include both carbonated soft and non-carbonated soft drinks. Its soft drinks business includes both its own production and agreements with PepsiCo related to bottling and distribution. The brands that are distributed under these agreements are Pepsi, 7UP and Gatorade. AmBev has long-term agreements with PepsiCo whereby AmBev has the exclusive right to bottle, sell and distribute certain brands of PepsiCo�� portfolio of carbonated soft drinks in Brazil. In the United States, Anheuser-Busch also produces non-alcoholic malt beverage products, including O��oul�� and O��oul�� Amber, energy drinks and related products. In the United States, its indirect subsidiary, Metal Container Corporation, manufactures beverage cans at eight plants and beverage can lids at three plants for sale to its Anheuser-Busch beer operations and United States soft drink customers. Anheuser-Busch also owns a recycling business, which buys and sells used beverage containers and recycles aluminum and plastic containers; a manufacturer of crown liner materials for sale to its North American beer operations, and a glass manufacturing plant which manufactures glass bottles for use by its North American beer operations. Advisors' Opinion:- [By Nicole Seghetti]
Beer war beneficiary
In mid-2012, Anheuser-Busch InBev (NYSE: BUD ) agreed to sell its 50% stake in the Crown Imports joint venture to Constellation, giving Constellation complete control of Crown and rights for Grupo Modelo� (NASDAQOTH: GPMCY ) brands in the U.S. - [By Nickey Friedman]
Ever since Constellation Brands (NYSE: STZ ) acquired Grupo Modelo's U.S. beer business from Anheuser-Busch InBev (NYSE: BUD ) for nearly $5 billion, the company has been seeing unprecedented success. Perhaps it's a sign Anheuser-Busch InBev sold out too cheap, or worse, a sign of inept management. In any event, Anheuser-Busch InBev's loss is Constellation Brands' gain as it competes against other hot beer brands such as those from Boston Beer (NYSE: SAM ) .
10 Best Quality Stocks To Invest In Right Now: Administradora de Fondos de Pensiones-Provida S.A.(PVD)
Administradora de Fondos de Pensiones Provida S.A. offers private pension fund administration and related services in the Republic of Chile. Its services include collection for individual capitalization accounts, voluntary savings accounts, voluntary pension savings, life and disability benefits, investment services, and accounts administration. The company also holds investments in private pension fund administrators operating in Peru, Ecuador, Mexico, and the Dominican Republic. As of June 30, 2005, it operated 134 branches. The company was incorporated in 1981 and is headquartered in Santiago, Chile. Administradora de Fondos de Pensiones Provida SA operates as a subsidiary of Banco Bilbao Vizcaya Argentaria, Chile S.A.
Advisors' Opinion:- [By John Udovich]
While America�� middle class appears to be shrinking with little upward mobility, small cap wealth management stocks Noah Holdings Limited (NYSE: NOAH) and A.F.P Provida SA (NYSE: PVD)�plus larger cap Affiliated Managers Group, Inc (NYSE: AMG) are managing money in places where the ranks of the middle class and the wealthy are still growing strong. Specifically, Noah Holdings Limited is based in China, Chile based A.F.P Provida SA is spreading its footprint into other Latin American countries and the�Affiliated Managers Group is growing�a global footprint. For those reasons, you have probably not heard of these wealth management stocks, but here are some reasons why you might want to consider investing in one:
10 Best Quality Stocks To Invest In Right Now: CTS Corporation (CTS)
CTS Corporation engages in the design, manufacture, assembly, and sale of electronic components and sensors, as well as the provision of electronics manufacturing services. It offers automotive sensors and actuators used in commercial or consumer vehicles; electronic components used in communications infrastructure and computer markets; components used in computer and other high-speed applications, switches, resistor networks, and potentiometers; and fabricated piezoelectric materials and substrates used primarily in medical, industrial, defense and aerospace, and computer markets. The company markets and sells its products through its sales engineers, independent manufacturers� representatives, and distributors. It has operations in China, Japan, Scotland, Singapore, India, Taiwan, and the United States. CTS Corporation was founded in 1896 and is based in Elkhart, Indiana.
Advisors' Opinion:- [By Seth Jayson]
CTS (NYSE: CTS ) reported earnings on July 22. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), CTS missed estimates on revenues and beat expectations on earnings per share. - [By Marc Bastow]
When earnings reports roll in, so do the dividend increases. This week, we saw a veritable tidal wave of dividend increases, from Megacap stocks like Halliburton (HAL) and Whole Foods (WFM) to smaller players like� CTS Corporation (CTS), companies were scrambling to boost their dividend payouts. A total of 23 companies increased their dividends this week.
10 Best Quality Stocks To Invest In Right Now: C&J Energy Services Inc (CJES)
C&J Energy Services, Inc., incorporated on December 15, 2010, is a provider of hydraulic fracturing, coiled tubing, wireline and other complementary services with a focus on complex, technically demanding well completions. The Company also manufactures and repairs equipment to fulfill its internal needs and for third-party companies in the energy services industry. The Company operates in three reportable segments: Stimulation and Well Intervention Services, Wireline Services and Equipment Manufacturing.
The Company provides hydraulic fracturing coiled tubing and related well intervention services through its Stimulation and Well Intervention Services segment to oil and natural gas exploration and production companies. On June 7, 2012, the Company acquired Casedhole Holdings, Inc. and its operating subsidiaries, including Casedhole Solutions, Inc.
Stimulation and Well Intervention Services
The Company's Stimulation and Well Intervention Services segment provides hydraulic fracturing and coiled tubing and other well intervention services, with a focus on complex, technically demanding well completions. The Company's customers use the Company's hydraulic fracturing services to enhance the production of oil and natural gas from formations with low permeability, which restricts the natural flow of hydrocarbons. Hydraulic fracturing involves pumping a fluid down a well casing or tubing at sufficient pressure to cause the underground producing formation to fracture, allowing the oil or natural gas to flow more freely. The Company's engineering staff also provides technical evaluation, job design and fluid recommendations for the Company's customers as an integral element of its fracturing service. The Company's engineering staff also provides technical evaluation, job design and fluid recommendations for the Company's customers as an integral element of its fracturing service.
Wireline Services
The Company's Wireline Services segment p! rovides cased-hole wireline and other complementary services. Its services includes logging, perforating, pipe recovery, pressure testing and pumpdown services, which are critical throughout a well's life cycle.
Equipment Manufacturing
The Company's Equipment Manufacturing segment constructs oilfield equipment, including hydraulic fracturing pumps, coiled tubing units, pressure pumping units and other equipment for the Company's Stimulation and Well Intervention Services and Wireline Services segments as well as for third-party customers in the energy services industry. This segment also provides equipment repair services and oilfield parts and supplies to the energy services industry and to meet the Company's own internal needs.
The Company competes with Halliburton, Schlumberger, Baker Hughes, Weatherford International, RPC, Inc., Pumpco, an affiliate of Superior Energy Services, Frac Tech, Stewart & Stevenson, Enerflow Industries Inc., United Engines Manufacturing, Dragon Products and National Oilwell Varco, Inc.
Advisors' Opinion:- [By Matt DiLallo]
C&J Energy Services (NYSE: CJES )
One of the more interesting purchases this quarter is the $7.4 million Soros poured into C&J Energy Services. The oilfield service company specializes in complex well completions, making it an important company for extracting ever-harder-to-reach oil and gas. With operations spanning the most active shale plays, an investment in C&J is one that benefits as oil and gas companies drill more wells using even more complex hydraulic fracturing techniques. - [By Roberto Pedone]
One oil and gas equipment and services player that insiders are active in here is C&J Energy Services (CJES), which provides hydraulic fracturing, coiled tubing, wireline, and other complementary services to oil and gas exploration and production companies in the U.S. Insiders are buying this stock into major weakness, since shares have dropped sharply lower over the last three months by 34%.
C&J Energy Services has a market cap of $1 billion and an enterprise value of $1.3 billion. This stock trades at a cheap valuation, with a trailing price-to-earnings of 19.8 and a forward price-to-earnings of 9.9. Its estimated growth rate for this year is 10.7%, and for next year it's pegged at 42.2%. This is not a cash-rich company, since the total cash position on its balance sheet is $20.30 million and its total debt is $345.85 million.
A director just bought 340,887 shares, or about $6.38 million worth of stock, at $18.69 per share.
From a technical perspective, CJES is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has recently started to rebound higher off its new 52-week low of $16.66 a share. That rebound is now starting to push shares of CJES within range of triggering a near-term breakout trade.
If you're bullish on CJES, then I would look for long-biased trades as long as this stock is trending above its new 52-week low of $16.66 and then once it breaks out above some key near-term overhead resistance at $19.86 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.41 million shares. If that breakout hits soon, then CJES will set up to re-test or possibly take out its next major overhead resistance levels $21.66 to its 50-day moving average of $23.63 a share.
Must Read: Can These 22 New Restaurant Foods and Drinks Feed Investors Too?
- [By Roberto Pedone]
C&J Energy Services (CJES), through its subsidiaries, provides hydraulic fracturing, coiled tubing, wireline and other complementary services to oil and gas exploration and production companies in the U.S. This stock closed up 2.9% at $29.55 in Wednesday's trading session.
Wednesday's Volume: 1.95 million
Three-Month Average Volume: 879,264
Volume % Change: 161%From a technical perspective, CJES spiked notably higher here right above its 200-day moving average of $28.06 and back above its 50-day moving average of $29.55 with above-average volume. This move to the upside on Wednesday also pushed shares of CJES into breakout territory, since the stock took out some near-term overhead resistance at $29.27. Shares of CJES are now starting to trend within range of triggering another breakout trade. That trade will hit if CJES manages to clear Wednesday's intraday high of $29.69 to some more near-term overhead resistance at $30.16 with high volume.
Traders should now look for long-biased trades in CJES as long as it's trending above its 200-day at $28.06 and then once it sustains a move or close above those breakout levels with volume that hits near or above 879,264 shares. If that breakout develops soon, then CJES will set up to re-test or possibly take out its next major overhead resistance levels at $31.50 to $33
- [By Aaron Levitt]
For investors, the choice is clear — you need to focus globally when it comes to oil stocks. North American-focused oil stocks like C&J Energy (CJES) and Basic Energy Services (BAS) might not be up to snuff in such a highly challenging pricing environment.
10 Best Quality Stocks To Invest In Right Now: Cermaq ASA (CEQ)
Cermaq ASA is a Norway-based company active in the aquaculture industry. It is engaged in the farming of salmon and trout. The Company, along with its subsidiaries, operates in one business segment, namely Aquaculture, which consists of two divisions: Fish Feed production, which involves the production and sale of fish feed, and Fish Farming, which involves the breeding and on-growing, as well as the slaughtering, processing, sale and distribution of salmon and trout. The Company�� other activities consist of operations carried out through its subsidiary, Norgrain AS, the associated company, Denofa AS and the parent company. The Company operates through its subsidiaries, including Statkorn Aqua AS and Mainstream Norway AS, among others. In October 2013, the Company sold its second business segment, EWOS Group, to Altor Fund III and Bain Capital. Advisors' Opinion:- [By Chuck Carnevale]
Additional strengths supporting Aflac�� business model can be found by reviewing their common equity or book value (ceq), the lime green line on the following graph, in comparison to their current market value (mkval), the aqua colored more jagged line on the graph. Aflac�� book value has increased steadily except for a minor pause during the Great Recession of 2008. In contrast, their market value has been much more cyclical and erratic. I believe this additionally reflects current undervaluation of Aflac�� shares. This further supports my contention that Aflac is a great business that is currently on sale.
No comments:
Post a Comment